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Abnormalities of fixation, saccade and pursuit
in posterior cortical atrophy
Timothy J. Shakespeare,1 Diego Kaski,2 Keir X. X. Yong,1 Ross W. Paterson,1 Catherine
F. Slattery,1 Natalie S. Ryan,1 Jonathan M. Schott1 and Sebastian J. Crutch1
The clinico-neuroradiological syndrome posterior cortical atrophy is the cardinal ‘visual dementia’ and most common atypical
Alzheimer’s disease phenotype, offering insights into mechanisms underlying clinical heterogeneity, pathological propagation and
basic visual phenomena (e.g. visual crowding). Given the extensive attention paid to patients’ (higher order) perceptual function, it
is surprising that there have been no systematic analyses of basic oculomotor function in this population. Here 20 patients with
posterior cortical atrophy, 17 patients with typical Alzheimer’s disease and 22 healthy controls completed tests of ﬁxation, saccade
(including ﬁxation/target gap and overlap conditions) and smooth pursuit eye movements using an infrared pupil-tracking system.
Participants underwent detailed neuropsychological and neurological examinations, with a proportion also undertaking brain
imaging and analysis of molecular pathology. In contrast to informal clinical evaluations of oculomotor dysfunction frequency
(previous studies: 38%, current clinical examination: 33%), detailed eyetracking investigations revealed eye movement abnormal-
ities in 80% of patients with posterior cortical atrophy (compared to 17% typical Alzheimer’s disease, 5% controls). The greatest
differences between posterior cortical atrophy and typical Alzheimer’s disease were seen in saccadic performance. Patients with
posterior cortical atrophy made signiﬁcantly shorter saccades especially for distant targets. They also exhibited a signiﬁcant
exacerbation of the normal gap/overlap effect, consistent with ‘sticky ﬁxation’. Time to reach saccadic targets was signiﬁcantly
associated with parietal and occipital cortical thickness measures. On ﬁxation stability tasks, patients with typical Alzheimer’s
disease showed more square wave jerks whose frequency was associated with lower cerebellar grey matter volume, while patients
with posterior cortical atrophy showed large saccadic intrusions whose frequency correlated signiﬁcantly with generalized reduc-
tions in cortical thickness. Patients with both posterior cortical atrophy and typical Alzheimer’s disease showed lower gain in
smooth pursuit compared to controls. The current study establishes that eye movement abnormalities are near-ubiquitous in
posterior cortical atrophy, and highlights multiple aspects of saccadic performance which distinguish posterior cortical atrophy
from typical Alzheimer’s disease. We suggest the posterior cortical atrophy oculomotor proﬁle (e.g. exacerbation of the saccadic
gap/overlap effect, preserved saccadic velocity) reﬂects weak input from degraded occipito-parietal spatial representations of
stimulus location into a superior collicular spatial map for eye movement regulation. This may indicate greater impairment of
identiﬁcation of oculomotor targets rather than generation of oculomotor movements. The results highlight the critical role of
spatial attention and object identiﬁcation but also precise stimulus localization in explaining the complex real world perception
deﬁcits observed in posterior cortical atrophy and many other patients with dementia-related visual impairment.
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Introduction
Posterior cortical atrophy (PCA) is a clinico-radiological
syndrome characterized by insidious decline in visuopercep-
tual, visuospatial and other posterior cortical skills and at-
rophy of the parietal and occipital lobes (Benson et al.,
1988; Mendez et al., 2002; Tang-Wai et al., 2004; see
Crutch et al., 2012 for a review). The most common path-
ology in PCA is Alzheimer’s disease, and PCA is now
recognized in Alzheimer’s disease diagnostic and research
criteria as the most common atypical Alzheimer’s disease
phenotype (McKhann et al., 2011; Dubois et al., 2014).
However, the syndrome can also be caused by Lewy
body disease and corticobasal degeneration (Hof et al.,
1990; Tang-Wai et al., 2003; Renner et al., 2004; Kouri
et al., 2011). PCA is typically an early-onset, sporadic con-
dition (age 50–65 years) (Mendez et al., 2002; Tang-Wai
et al., 2004; McMonagle et al., 2006).
There is currently much greater discussion and examin-
ation of high-level object and space perception problems
than more fundamental deﬁcits of perceptual and oculo-
motor function. For example, impairment is widely
reported on tasks of higher order perception (e.g. non-
canonical object recognition, complex spatial analysis)
which rely on cognitive processes associated with parietal
and occipito-temporal mechanisms downstream in the
visual system. By contrast, more basic visual functions
(e.g. edge detection, form and motion coherence) which
may underpin many such downstream deﬁcits and which
are mediated largely by upstream occipital mechanisms,
have been largely overlooked (cf. Lehmann et al., 2011a).
Even more notable by their absence are any systematic stu-
dies of oculomotor function in PCA. Previous studies have
identiﬁed distinct oculomotor proﬁles differentiating demen-
tia populations (frontotemporal lobar degeneration, cortico-
basal degeneration, progressive supranuclear palsy, and
typical Alzheimer’s disease: Garbutt et al., 2008; Boxer
et al., 2012; amyotrophic lateral sclerosis: Sharma et al.,
2011; Huntington’s disease: Golding et al., 2006; Hicks
et al., 2008; progressive supranuclear palsy: Rohrer et al.,
2010) and associations between eye movements and higher
order perceptual and spatial functions (Bak et al., 2006), but
the proﬁle of oculomotor function in PCA has not yet been
determined. Some clinical reports of PCA have detailed the
frequency of symptoms such as oculomotor apraxia (e.g.
38% of 39 patients with PCA reported by Kas et al., 2011;
see also Mendez et al., 2002; Nestor et al., 2003; Tang-Wai
et al., 2004; McMonagle et al., 2006) and ‘sticky ﬁxation’ (a
deﬁcit in disengagement from a target; Delamont et al., 1989),
but estimates are largely derived from clinical examination or
inferred from clinical history or impairments observed on
other more complex tasks.
There are strong scientiﬁc and theoretical rationales for
investigating oculomotor function in PCA. Patients with
PCA (whether or not named as such) are frequently used
in neuroscientiﬁc investigations of a host of visual processes
such as visual crowding (Yong et al., 2014), visual salience
(Mannan et al., 2009; Foulsham et al., 2011), global/local
processing and simultanagnosia (Graff-Radford et al.,
1993; Coslett et al., 1995; Stark et al., 1997; Huberle
et al., 2010; Thomas et al., 2012; Shakespeare et al.,
2013) and letter-by-letter reading (Freedman et al., 1991;
Price and Humphreys, 1995). Therefore a sound under-
standing of lower-order oculomotor function in these pa-
tients is critical for the accurate interpretation of such
visuoperceptual and other impairments in patients with
PCA. Particularly given previous suggestions of impaired
disengagement from ﬁxation targets in PCA, this popula-
tion also offers the opportunity to disambiguate between
rival explanations of the normal gap/overlap effect (the lag
in generating a saccade to a new target when the current
ﬁxation target persists), which has variously been attributed
to parietal attentional disengagement and superior collicu-
lar active ﬁxation mechanisms (Csibra et al., 1997).
There are also strong anatomical and clinical rationales
for investigating oculomotor function in PCA. Disruption
of the parietal lobes—a primary site of atrophy in PCA
(Whitwell et al., 2007; Lehmann et al., 2011b)—results in
impaired saccadic latency, and deﬁcits in smooth pursuit
(Bogousslavsky and Regli, 1986; Pierrot-Deseilligny et al.,
1991; Braun et al., 1992). Furthermore, disruption of the
frontal eye ﬁelds—noted to be hypometabolic in PCA
(Nestor et al., 2003)—also results in oculomotor deﬁcits
such as increased saccadic latency, hypometric saccades,
and impairment of smooth pursuit (Pierrot-Deseilligny
et al., 1997). Thus one would expect to ﬁnd signiﬁcant
and frequent oculomotor abnormalities in patients with
PCA, in contrast to the current low estimates derived
from rudimentary clinical evaluations in the literature. It
should be noted that in the current study, we deliberately
restricted our investigations to pro- and not anti-saccade
tasks in order to minimize attentional and inhibitory task
demands and to focus on the role of the parietal eye ﬁelds
in reﬂexive as opposed to intentional eye movements (Pa
et al., 2014).
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In the current study we conducted the ﬁrst systematic
analysis of eye movement abnormalities in patients with
PCA compared to patients with typical Alzheimer’s disease
and healthy controls to address the central question of
what impact oculomotor function has on higher-order per-
ception in this syndrome. First we generated, compared and
contrasted oculomotor proﬁles for each group across
tests of ﬁxation stability, saccade generation and smooth
(sinusoidal) pursuit. Second we speciﬁcally examined pa-
tients’ ability to disengage attention and generate targets
for subsequent eye movements using a saccade gap/overlap
paradigm. Third we evaluated the relationship between
metrics of oculomotor function and performance on tests
of basic visual function and higher-order object and space
perception. Fourth we investigated the structural neural
correlates of ﬁxation, saccade and pursuit abilities in PCA.
Materials and methods
Participants
Patient demographics
Data were collected from 20 patients with PCA (eight male),
17 patients with typical Alzheimer’s disease (nine male) and 22
healthy controls (ﬁve male). Patients with PCA fulﬁlled stand-
ard clinical criteria for PCA (Mendez et al., 2002; Tang-Wai
et al., 2004) and had a clinical diagnosis of probable
Alzheimer’s disease (Dubois et al., 2007, 2010). Patients with
typical Alzheimer’s disease fulﬁlled Dubois criteria for
Alzheimer’s disease. At testing, 12 patients with typical
Alzheimer’s disease and 13 patients with PCA were receiving
treatment with acetyl-cholinesterase inhibitors. One patient
with typical Alzheimer’s disease was receiving treatment with
an NMDA (N-methyl D-aspartate) antagonist, and one patient
with typical Alzheimer’s disease was receiving combined treat-
ment with an acetyl-cholinesterase inhibitor and NMDA an-
tagonist. Seven patients with typical Alzheimer’s disease and
one with PCA were receiving treatment with antidepressants.
All participants completed the ﬁxation task. Four patients
with PCA did not complete the saccade task and two patients
with PCA completed only the ﬁrst two blocks of the saccade
task, with four of these patients not completing the pursuit
task due to fatigue. Five patients with typical Alzheimer’s dis-
ease did not complete the saccade task, one patient with typ-
ical Alzheimer’s disease did not complete the pursuit task. This
project was approved by the NRES Committee London, Queen
Square, and all participants provided written informed consent
according to guidelines established by the Declaration of
Helsinki.
Clinical presentation
In the PCA group, with the exception of one patient in whom
the ﬁrst noted symptom was repeating questions (closely
followed by visuospatial symptoms), all patients with PCA re-
ported their initial symptoms to be visuospatial, visuopercep-
tual or calculation difﬁculties (neuropsychological test scores
of patients with PCA are presented in Supplementary Table 1).
In the typical Alzheimer’s disease group, 15 patients reported
episodic memory problems as their ﬁrst symptom, one patient
had word-ﬁnding difﬁculties followed by episodic memory and
one patient had difﬁculties in navigation closely followed by
episodic memory. Three of the patients with PCA had an
amyloid (ﬂorbetapir) PET scan, performed as part of another
study. Seven patients with PCA and 11 with typical
Alzheimer’s disease had undergone CSF examination with
measurement of amyloid-b1-42 and tau as part of their diag-
nostic evaluation.
Eighteen of 20 patients with PCA underwent neurological
assessment performed by trained clinicians with expertise in
the ﬁeld of dementia (mean time interval between neurological
and computerized eye movement assessment = 4.1 months).
Oculomotor function was examined clinically with respect to
the range of eye movements, subjective quality of pursuit
movements and saccadic accuracy and speed. Any abnormality
noted was qualiﬁed with a free text description of the deﬁcit.
Equipment
Stimuli were presented on a Dell Inspiron One desktop com-
puter from a ﬁxed viewing distance of 60 cm. Eye movements
were recorded using a head-mounted infrared video-based eye
tracker (Eyelink II; SR Research). Gaze position was recorded
at 250Hz and corneal reﬂection was used when possible (n = 8
PCA, n = 5 typical Alzheimer’s disease, n = 13 healthy con-
trols). Participants used a chin rest (wide HeadSpot;
University of Houston College of Optometry) to provide sta-
bility and maintain viewing distance throughout the experi-
ment. Saccades were parsed by the Eyelink system, using
standard velocity and acceleration thresholds (30/s and
8000/s2). Periods during which no saccadic movement
occurred were automatically identiﬁed as ﬁxation periods.
We used built-in programs provided with the eye tracker for
calibration and validation purposes (ﬁve points presented in a
random sequence). All the data analysed were obtained from
recordings with an average Cartesian prediction error of 51
during the validation procedures. Calibration was repeated
before the start of a new task if participants needed a break
from the eye tracker between tasks, or if there was slippage of
the eye tracker between tasks. Each trial was initiated by a
single target presented at the centre of the display (drift correct
stimulus; grey inner circle (0.1) with black outer circle (sub-
tending 0.4 of visual angle). When the participant was ﬁxat-
ing the target the experimenter initiated the trial, and any
discrepancy between gaze location and the target location
was corrected.
Procedure
Testing took place in a quiet darkened room. All stimuli were
presented on the display with a mid-grey background (RGB
128,128,128). The experimenter conducted experimental pro-
cedures positioned outside the participants’ ﬁeld of view.
Fixation stability
Following the centrally presented drift correct stimulus, a red
cross (RGB 255,0,0) subtending 0.5 of visual angle was pre-
sented. Participants were given one practice trial followed by a
further three trials, in each trial the stimulus was presented for
10 s (following Crossland and Rubin, 2002). Participants were
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instructed to ‘look as closely as you can at the red cross with-
out blinking for 10 seconds’.
Saccade assessment (gap and overlap conditions)
In the saccade task participants initially ﬁxated a centrally
presented stimulus, and were instructed to ‘look as quickly
and accurately as you can to the new dot when it appears’
(following Garbutt et al., 2008). The central ﬁxation point was
always presented for 500ms. There were two target
conditions:
(i) Gap condition: in half the trials target onset occurred 200ms
after ﬁxation offset, so that there was only ever one stimulus
on the screen at a given time.
(ii) Overlap condition: in the other half of trials, target onset
occurred 200ms prior to ﬁxation offset, so that for that 200ms
period two stimuli were simultaneously present on the screen
(Kapoula et al., 2010; Crawford et al., 2013; Yang et al., 2013).
In both conditions, the central ﬁxation point was a circle the
same size as that used for the drift correction, but with a white
inner circle. The target was a larger version (inner white circle
diameter 0.25, outer black circle diameter 0.75). Once pre-
sented, the target remained on the display until a ﬁxation of
minimum 250ms duration was made within 1.5 of visual
angle of the centre of the target, or until 5000ms from
target onset. Target stimuli were presented at 5, 10 and 15
horizontally, and 5 and 10 vertically from the centre of the
display, giving a total of 10 target locations. There were four
trials at each target location, yielding a total of 40 trials. There
were an equal number of targets at each location in the gap
and overlap conditions. Trials were split into four equal blocks
(n = 10 each), with target locations randomized and balanced
within each block, and all 10 target locations used within each
block (with no locations repeated). The gap/overlap condition
was alternated in an ABBA block design.
The saccade experiment included an additional condition in
which the target made a small ‘jittering’ movement around the
centre of the target location. There were 10 trials in each block
interleaved with the stationary target trials in a randomized
order. These trials were not analysed for the present study in
order to retain the focus on low-level control mechanisms and
to maintain clarity.
Sinusoidal pursuit
Two practice trials (one horizontal, then one vertical) were
followed by six trials of sinusoidal pursuit, three horizontal
and three vertical. The pursuit target was a red (RGB
255,0,0) circle 0.5 of visual angle in diameter. The movement
had a total amplitude of 20 (10 either side of the centre).
The frequency of the sinusoidal target oscillation was set at
0.25Hz and each trial lasted 10 s (2.5 cycles). Each trial was
initiated by the experimenter after a short interval allowing
participants to re-orient to a central ﬁxation point, from
which the movement started.
Analysis
Statistical analysis was carried out using Stata (v12.1) for each
of the metrics described below with group as the independent
variable, and age included as a covariate of no interest.
Fixation stability
Data from the practice trial were discarded.
Number of square wave jerks
Square wave jerks were deﬁned as a saccade of 52 in amp-
litude, taking the gaze away from the target position, followed
within 300ms by another saccade with an amplitude similar to
the ﬁrst (difference in amplitude between saccades 50.75),
which takes gaze back towards the target position (Leigh
and Zee, 2006). The number of square wave jerks during
the ﬁxation period for each participant was counted using an
algorithm implementing the above rules.
Number of large intrusive saccades
Saccades containing blinks were removed. The number of sac-
cades greater than 2 in amplitude was counted for each par-
ticipant (Bylsma et al., 1995).
Longest period of ﬁxation
The maximum period of ﬁxation (length of time between sac-
cades) over all three trials was recorded for each participant
(Bylsma et al., 1995).
Saccade assessment
For the analysis of saccadic metrics, the stimulus eccentricity
and whether the trial was a gap or overlap trial were included
as additional independent variables.
Time to ﬁrst ﬁxation upon target
The time between the onset of the target and the ﬁrst ﬁx-
ation made within 2.5 of the target was compared between
groups. Time to ﬁrst ﬁxation upon target was not normally
distributed, so analysis was performed on a square-root trans-
form, with values greater or less than the two standard devi-
ations from the mean of each group removed after
transformation.
Amplitude, latency and velocity of ﬁrst major saccade
Saccade amplitude, velocity and latency were calculated for the
ﬁrst major saccade towards the target (similar to Garbutt
et al., 2008). This saccade was identiﬁed using a predetermined
algorithm based on pilot work; any saccade that included a
blink, started before the target appears, started more than 2.5
from the central ﬁxation point, or was in the wrong direction
(error in angle of more than 45) was removed. The ﬁrst sac-
cade remaining for each trial was kept. A trial was discarded if
the saccade for that trial was the sixth saccade or later. The
percentage of trials removed as a result of this procedure was
6.5% in healthy controls, 7.9% in typical Alzheimer’s disease
and 11.3% in PCA.
The error in saccade amplitude was calculated as the differ-
ence between the amplitude of the main saccade and the ec-
centricity of the target. A positive value represents overshoot
(hypermetria) whereas a negative value represents undershoot
(hypometria).
Saccade latency was calculated as the time between onset of
the target and the start of the main saccade (identiﬁed auto-
matically using the algorithm described above). The distribu-
tion of saccade latency was very skew, so analysis was
performed on a square-root transform of latency, with values
of saccade latency greater or less than the two standard devi-
ations from the mean of each group removed after
transformation.
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Peak saccadic velocity is very closely related to saccade amp-
litude (Boghen et al., 1974), thus if saccadic amplitude was
reduced in a patient group, we would expect peak saccadic
velocity to also be reduced. Therefore in the comparison of
peak saccadic velocity between groups, saccade amplitude
was included as a covariate of no interest so that differences
in velocity could be analysed independently from differences in
saccadic amplitude. Saccade amplitude and velocity were pro-
vided by the Eyelink software.
Number of saccades made
The number of saccades that were made after the target ap-
peared, did not include a blink and were greater than 2 was
counted.
Sinusoidal pursuit
In the analysis of sinusoidal pursuit, pursuit direction (hori-
zontal versus vertical) was included as an additional independ-
ent variable.
Pursuit gain
Pursuit gain (the ratio of eye velocity to target velocity) was
calculated using Stata (v12.1) for each measurement sample of
the eye tracker using instantaneous estimates (provided by the
Eyelink system) of stimulus and gaze velocity. Blinks, saccades
and periods of pupil occlusion (and samples 50ms either side
of any of these) were removed; this resulted in removing 4% of
samples in healthy controls, 5% in typical Alzheimer’s disease
and 6% in PCA. Gain was calculated for the remaining period,
and outliers were removed [due to the differing nature of this
measurement, the method used to remove outliers for latencies
(removing samples where gain was greater than two standard
deviations from the mean of that participant’s group) removed
too much of the distribution of gain values, resulting in a
biased group comparison; thus outliers were removed by cut-
ting off the tails of the distribution of gain, deﬁned by visual
inspection of histograms, at 1 and + 2].
Number of saccades
The number of saccades of amplitude greater than 2 was
counted (not including blinks).
Receiver operator characteristic analysis
The extent of separation between the two groups at the indi-
vidual patient level (rather than just in terms of the group
means and variances) was investigated using a receiver oper-
ator characteristic (ROC) analysis. Analysis was carried out
for the classiﬁcation of patients with PCA and typical
Alzheimer’s disease for each oculomotor metric, choosing the
cut-off that maximized the percentage of patients correctly
classiﬁed (accuracy). An additional analysis was carried out
for the differentiation of patients (both PCA and typical
Alzheimer’s disease) from healthy controls.
Correlations between oculomotor metrics and
perceptual abilities
Pearson pairwise correlations and post hoc Bonferroni correc-
tions were calculated between subsets of oculomotor metrics
(number of square wave jerks and large saccades on ﬁxation,
saccade time to target, major saccade amplitude error and la-
tency, and pursuit gain) and neuropsychological test scores
(basic visual processing: ﬁgure-ground discrimination, shape
discrimination; visuospatial: dot counting, number location;
visuoperceptual: object decision, fragmented letters; non-
visual tasks: graded difﬁculty arithmetic, short recognition
memory test for words). Detailed descriptions of each of
these neuropsychological tests and a table of individual test
scores is presented in the Supplementary material.
Neuroimaging
Thirteen patients with PCA and seven patients with typical
Alzheimer’s disease who completed the eye-tracking assess-
ments also had volumetric MRI available. Scans from 25
healthy controls were used for comparison (these are separate
from the eye tracking controls, as those participants did not
receive scans). T1-weighted volumetric MRI brain scans were
acquired on a 3.0T Siemens TIM Trio scanner using a mag-
netization prepared rapid gradient echo sequence with a
28.2 cm ﬁeld-of-view to provide 208 contiguous 1.1mm
thick slices. Cortical thickness measurements were made
using FreeSurfer version 5.3.0 (http://surfer.nmr.mgh.harvard.
edu/). The detailed procedure has been described and validated
in previous publications (Dale et al., 1999; Fischl and Dale,
2000). Two modiﬁcations to the standard FreeSurfer process-
ing stream were made: a locally generated brain mask was
used to improve skull stripping, and FreeSurfer ventricular
segmentations were added to the white matter mask to im-
prove cortical segmentation.
Cortical thickness values were extracted for 34 brain areas
in the left and right hemisphere using FreeSurfer’s Desikan
parcellation (Desikan et al., 2006). These areas were grouped
into ﬁve larger regions: central, frontal, parietal, temporal, and
occipital (following Ryan et al., 2014; Supplementary Table 2).
Cerebellar grey matter volume was extracted using FreeSurfer’s
automatic subcortical segmentation (Fischl et al., 2002).
In statistical analysis, cortical thickness was the dependent
variable for the cortical regions, and volume was the depend-
ent variable for the cerebellar grey matter. Group was the in-
dependent variable. Age, gender and total intracranial volume
were included as additional covariates for adjustment.
Associations with task performance were assessed in a com-
bined patient group (patients with PCA and typical
Alzheimer’s disease) to increase power.
Results
Patient characteristics
In terms of age at assessment, the PCA group [63.2 (8.9)]
did not differ signiﬁcantly from the healthy control group
[mean (standard deviation, SD) age = 63.3 (6.2) years; two-
sample t-test P = 0.97] or the typical Alzheimer’s disease
group [mean (SD) age = 67.4 (5.9) years; P = 0.11].
However the typical Alzheimer’s disease group was signiﬁ-
cantly older than the healthy control group (P = 0.047). As
described in the ‘Analysis’ section, age was included as a
covariate in statistical analyses.
The PCA and typical Alzheimer’s disease groups did not
differ in terms of disease duration [PCA: 4.6 (2.0) years;
typical Alzheimer’s disease: 5.1 (2.4) years; P = 0.44] or
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Mini-Mental State Examination score [PCA: 18.8 (4.5);
typical Alzheimer’s disease: 20.1 (5.2); P = 0.41].
Biomarkers of molecular pathology were available in
10/20 PCA and 11/17 typical Alzheimer’s disease patients
(Table 1). These were supportive of underlying Alzheimer’s
disease pathology in 8/10 PCA cases, compatible with
Alzheimer’s disease in one case, with one case atypical
for Alzheimer’s disease. In the typical Alzheimer’s disease
group CSF was supportive of underlying Alzheimer’s dis-
ease in 10/11 cases, and atypical in one case.
Eighteen patients with PCA underwent clinical assess-
ment of eye movements. Of these, 6/18 (33%) were noted
to have eye movement abnormalities. These were hypo-
metric saccades (n = 2), slow saccades (n = 1), gaze imper-
sistence (n = 1), broken smooth pursuit (n = 1) and head
thrust (n = 1). Case reports including clinical examination
of eye movements from two patients with PCA with bio-
markers suggestive of Alzheimer’s disease are presented in
the Supplementary material.
Fixation stability
Mean and standard deviation performance metrics for the
ﬁxation stability task are given in Table 2. Effect sizes
(Cohen’s d) are presented in Supplementary Table 3.
Square wave jerks
Position traces for one participant from each group (con-
trol, typical Alzheimer’s disease, PCA) are shown in Fig. 1
to illustrate differences in the frequency of square wave
jerks. The frequency of square wave jerks per trial did
not differ signiﬁcantly between patients with PCA and
healthy controls [1.50 (2.20); P = 0.16]. A higher frequency
of square wave jerks was observed in the patients with
typical Alzheimer’s disease than patients with PCA
(P = 0.02) or healthy controls (P5 0.001).
Number of large intrusive saccades
Patients with PCA showed a greater frequency of large in-
trusive saccades than healthy controls (P = 0.006), but did
not differ signiﬁcantly from patients with typical
Alzheimer’s disease (P = 0.41). There was only a trend to-
wards a greater frequency of large saccades in patients with
typical Alzheimer’s disease than healthy controls (P = 0.07).
Longest period of fixation
The longest period of ﬁxation was shorter in the PCA
group than the control group (P = 0.002) but did not
differ from the typical Alzheimer’s disease group
(P = 0.81). Patients with typical Alzheimer’s disease
showed a shorter maximum ﬁxation period than the
healthy controls (P = 0.002).
Saccade assessment
Example traces from one participant from each group
(control, typical Alzheimer’s disease, PCA) illustrating dif-
ferences in their saccades, are presented in Fig. 2. Mean
and standard deviation performance metrics for the saccade
task are given in Table 2. Effect sizes (Cohen’s d) are pre-
sented in Supplementary Table 3.
Time to first fixation upon target
Patients with PCA took longer to reach the target at each
eccentricity than patients with typical Alzheimer’s disease
(5 P = 0.005, 10 P5 0.001, 15 P = 0.002) or controls
(5 P5 0.001, 10 P5 0.001, 15 P50.001). Latencies
in the typical Alzheimer’s disease group were not statistic-
ally different from those in controls at 5 or 10 of eccen-
tricity, and there was only a trend at 15 (5 P = 0.28, 10
P = 0.21, 15 P = 0.07). This difference in time taken to
ﬁxate the target between patients with PCA and controls/
patients with typical Alzheimer’s disease was greater at
Table 1 Molecular pathology biomarkers in patients
Diagnosis PCA PCA PCA PCA PCA PCA PCA PCA PCA PCA
Amyloid 18F imaging N/A N/A N/A N/A N/A N/A N/A Positive Positive Positive
CSF total tau (pg/ml) 841 787 325 412 561 310 898 N/A N/A N/A
CSF Ab1-42 (pg/ml) 264 297 177 402 451 488 702 N/A N/A N/A
CSF tau: Ab ratio 3.19 2.65 1.84 1.02 1.24 0.64 1.28 N/A N/A N/A
Biomarker interpretation + + + + + + /  + + +
Diagnosis tAD tAD tAD tAD tAD tAD tAD tAD tAD tAD tAD
Amyloid 18F imaging N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
CSF total tau (pg/ml) 828 843 1099 600 800 371 289 466 41200 2722 203
CSF Ab1-42 (pg/ml) 125 129 195 125 297 245 280 298 452 528 511
CSF tau: Ab ratio 6.62 6.53 5.64 4.80 2.69 1.51 1.03 1.56 2.65 5.16 0.40
Biomarker interpretation + + + + + + + + + + 
+ = Supportive of Alzheimer’s disease (either positive 18 F florbetapir amyloid scan or CSF amyloid-b1-425 550 pg/ml and tau:amyloid-b ratio4 1).
+ / = Compatible with Alzheimer’s disease (borderline level of CSF amyloidb1-42 or ratio).
 = Atypical for Alzheimer’s disease.
Ab = amyloid-b; tAD = typical Alzheimer’s disease; N/A = not available.
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longer stimulus distances (interaction between group and
distance P5 0.001).
Gap/overlap condition effect
There was also a signiﬁcant interaction between group and
the effect of the gap/overlap manipulation (group  gap/
overlap interaction; P = 0.003; Fig. 3). Post hoc pairwise
interaction analyses revealed that this main group  gap/
overlap interaction reﬂected patients with PCA taking pro-
portionally longer to reach the target in the overlap than
gap condition compared with either patients with typical
Alzheimer’s disease (P = 0.01) or controls (P = 0.01). By
Table 2 Mean and standard deviation performance metrics for PCA, typical Alzheimer’s disease and control groups
on the fixation stability, saccade and sinusoidal pursuit tasks
PCA Typical Alzheimer’s disease Control
Mean (SD) Mean (SD) Mean (SD)
Fixation stability
Square wave jerk frequency 3.15 (3.36) 6.00 (5.30)a,c 1.50 (2.20)
Large intrusive saccade frequency 6.50 (7.10)a 4.53 (8.19) 1.00 (2.00)
Longest period of fixation (ms) 4366 (3038)a 4134 (3032)a 7321 (2709)
Saccade task
Time to fixation on target (ms) 5 567.4 (332.8)a,b 321.1 (126.1) 310.6 (121.3)
10 862.9 (433.4)a,b 453.6 (261.7) 359.9 (90.6)
15 892.4 (550.8)a,b 614.6 (439.9) 425.7 (153.4)
Latency (ms) 5 339.1 (131.1)a,b 232.6 (41.3) 219.2 (46.3)
10 398.5 (129.3)a,b 270.2 (86.6) 226.7 (30.4)
15 411.8 (201.2)a 333.6 (135.3) 237.8 (38.8)
Amplitude error () 5 1.34 (0.67)a,b 0.26 (0.64) 0.49 (0.55)
10 3.51 (1.58)a,b 1.60 (1.47) 1.44 (0.90)
15 6.34 (2.52)a,b 3.02 (2.22) 2.29 (1.26)
Velocity (/s) 264.0 (64.0) 334.3 (53.7)a,c 294.9 (60.5)
Number of saccades made 2.08 (0.78)a 1.53 (0.61) 1.21 (0.16)
Sinusoidal pursuit
Pursuit gain 0.38 (0.17)a 0.46 (0.15)a 0.61 (0.16)
Number of saccades per trial 13.06 (4.67)a 13.35 (4.71)a 7.40 (4.21)
aPatient group performance significantly worse than controls (bold text).
bPCA group performance significantly worse than typical Alzheimer’s disease group performance (cells highlighted).
cTypical Alzheimer’s disease group performance significantly different from PCA group performance (cells highlighted).
All marked (a,b,c) significant comparisons indicate P4 0.05; see text for exact significance values.
Figure 1 Representative traces from the fixation task in a healthy control, a patient with typical Alzheimer’s disease and a
PCA patient. The upper plot (grey line) for each participant shows gaze position in the y (vertical) axis, the lower plot (black line) shows gaze
position in the x (horizontal) axis. The location of the target stimulus is represented by thin black lines behind the traces. Gridlines show
displacement of 1 of visual angle. The grey area in the plot for the PCA patient represents a blink (therefore x and y gaze coordinates are not
available for this period). Positive values of gaze position indicate rightward gaze. The healthy control maintains steady fixation upon the target,
whilst both patients show saccadic intrusions in the form of square-wave jerks. Additional large saccadic intrusions are evident in the PCA trace.
tAD = typical Alzheimer’s disease.
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contrast there was no signiﬁcant interaction between pa-
tients with typical Alzheimer’s disease and controls
(P = 0.39).
Latency, amplitude and velocity of first major
saccade
Saccade latency
Patients with PCA had longer latencies for the ﬁrst major
saccade towards the target than the control group at each
target distance (5 P5 0.001, 10 P5 0.001, 15
P = 0.0497) and longer latencies than the typical
Alzheimer’s disease group at 5 (P = 0.02) and 10
(P = 0.007), but not at 15 (P = 0.22). Latencies in the typ-
ical Alzheimer’s disease group were not statistically differ-
ent from those in controls at any target distance
(5 P = 0.27, 10 P = 0.29 and 15 P = 0.16). There was
no statistically signiﬁcant interaction between group and
target distance (i.e. the difference in saccade latencies
between groups was similar for each target distance;
P = 0.67).
Saccade amplitude error
The main saccade towards the target was hypometric rather
than hypermetric on average in each participant group, for
each target distance (5, 10 and 15). PCA patients’ main
saccades had a smaller amplitude at each target distance
than either controls (5 P5 0.001, 10 P50.001, 15
P5 0.001) or patients with typical Alzheimer’s disease
(5 P = 0.001, 10 P50.002, 15 P = 0.001). There were
no signiﬁcant differences between patients with typical
Alzheimer’s disease and controls in saccade amplitude
error at any of the target distances (5 P = 0.59, 10
P = 0.61, 15 P = 0.18). There was an interaction between
the effect of group and target distance (P5 0.001), with
the difference between the patients with PCA and patients
with typical Alzheimer’s disease/controls increasing with
increasing target distance.
Figure 2 Representative traces from the saccade task for a healthy control, a patient with typical Alzheimer’s disease and a
PCA patient in an ‘overlap’ trial. The upper plot (grey line) for each participant shows gaze position in the y (vertical) axis, the lower plot
(black line) shows gaze position in the x (horizontal) axis. Gridlines show displacement of 1 of visual angle. Positive values of gaze position
indicate rightward gaze. A central fixation point was present from the start of the trial until time point B (500 ms). The target appeared at 10
horizontally to the right of the central fixation point at time point A (300 ms) and remained present until the end of the trial. The healthy control
and patients with typical Alzheimer’s disease make a single saccade towards the target. The PCA patient takes a long time to initiate their first
saccade (in the incorrect direction), followed by a number of small saccades to reach the target location. tAD = typical Alzheimer’s disease.
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Saccade velocity
Saccade velocity (once saccade amplitude was accounted
for) did not differ signiﬁcantly between the PCA and con-
trol groups (P = 0.33). However, patients with typical
Alzheimer’s disease showed increased peak saccadic vel-
ocity compared to both patients with PCA (P = 0.02) and
healthy controls (P = 0.005).
Number of saccades made
Patients with PCA made more saccades per trial than
healthy controls (P5 0.001) but showed only a trend to-
wards more saccades than patients with typical Alzheimer’s
disease (P = 0.07). Patients with typical Alzheimer’s disease
only showed a trend towards more saccades than healthy
controls (P = 0.06).
Sinusoidal pursuit
Example traces from three participants illustrating perform-
ance in smooth pursuit are shown in Fig. 4. Mean and
standard deviation performance metrics for the sinusoidal
pursuit task are given in Table 2. Effect sizes (Cohen’s d)
are presented in Supplementary Table 3.
Pursuit gain
Mean pursuit gain was signiﬁcantly lower in the PCA
group than the healthy control group (P5 0.001), but
only a trend towards lower gain than the typical
Alzheimer’s disease group (P = 0.09). The typical
Alzheimer’s disease group also showed signiﬁcantly lower
gain than the control group (P = 0.01). Whilst participants
showed lower gain for vertical compared to horizontal pur-
suit (mean difference in gain of 0.23 between conditions;
P5 0.001), this effect was similar between patient groups
(no interaction between group and pursuit direction;
P = 0.93).
Number of saccades
Patients with PCA made more saccades per trial than
healthy controls (P5 0.001), but did not differ from pa-
tients with typical Alzheimer’s disease (P = 0.94). Typical
Alzheimer’s disease patients also made more saccades per
trial than controls (P50.001).
Rate of oculomotor impairment and receiver
operator characteristic analysis
Performance at the level of individual participants revealed
a large separation between groups. Impaired performance
was classed as a score more than 2 SD worse than healthy
control performance. We looked at the proportion of pa-
tients and controls with impairments in more than one
metric of saccadic performance: 12/15 (80%) of patients
with PCA were impaired on more than one metric com-
pared with only 2/12 (17%) of patients with typical
Alzheimer’s disease and 1/22 (5%) of healthy controls.
In the receiver operator characteristic analysis, the metric
with the greatest classiﬁcation accuracy in the discrimin-
ation between PCA and typical Alzheimer’s disease was
saccade amplitude error, which had a sensitivity of
93.8% and a speciﬁcity of 83.3%. Accuracy was higher
for metrics of saccade performance than metrics of ﬁxation
and pursuit performance; the results for the remaining met-
rics are shown in Supplementary Table 4. The results from
the receiver operator characteristic analysis for the discrim-
ination of a combined patient group (PCA and typical
Alzheimer’s disease) from healthy controls are presented
in Supplementary Table 5.
Association between oculomotor
metrics and perceptual abilities
In the PCA group, time to saccadic target and major sac-
cade latency each correlated signiﬁcantly with almost all six
basic visual, visuospatial and visuoperceptual tasks
(P5 0.05 for 10/12 comparisons) but not with calculation
or recognition memory scores (P4 0.05). None of the ﬁx-
ation or pursuit metrics correlated signiﬁcantly with percep-
tual scores. The only comparison to survive Bonferroni
corrections was the negative correlation between greater
major saccade latency and poorer basic visual processing
(shape discrimination test, r = 0.87, P50.001). In the
Figure 3 Interaction figure showing greater effect of
overlap condition on time taken to reach the interest area
in patients with PCA relative to patients with typical
Alzheimer’s disease and controls. AD = Alzheimer’s disease.
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typical Alzheimer’s disease group, there were signiﬁcant
pairwise correlations between time to saccadic target and
ﬁgure-ground discrimination, pursuit gain and shape dis-
crimination, and number of square wave jerks and calcula-
tion score. None of the typical Alzheimer’s disease
correlations survived Bonferroni correction.
Neuroimaging
P-values are provided in Table 3, and means and conﬁ-
dence intervals are presented in Fig. 5. Patients with PCA
had lower cortical thickness than patients with typical
Alzheimer’s disease and healthy controls in the parietal
Figure 4 Example traces from the pursuit task for a healthy control, a patient with typical Alzheimer’s disease and a PCA
patient. The figure shows a cycle towards the middle of the trial (seconds 4–8 from a trial of 10 s). Positive values of gaze position indicate
rightward gaze. The upper plot (grey line) for each participant shows gaze position in the y (vertical) axis, the lower plot (black line) shows gaze
position in the x (horizontal) axis. Target position is represented by a faint blue line. Gridlines show displacement of 1 of visual angle.
tAD = typical Alzheimer’s disease.
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and occipital lobes. In the frontal, temporal and central
regions, both patient groups had lower cortical thickness
than controls, but did not differ from one another. In the
cerebellar grey matter, patients with PCA had signiﬁcantly
lower volume than healthy controls, but did not differ sig-
niﬁcantly from patients with typical Alzheimer’s disease.
Patients with typical Alzheimer’s disease did not differ sig-
niﬁcantly from healthy controls.
In the combined patient group (patients with PCA and
typical Alzheimer’s disease) there was a signiﬁcant negative
correlation between a greater frequency of square wave
jerks during ﬁxation and lower cerebellar grey matter
volume, but not with any cortical area. By contrast, large
saccadic intrusion frequency was associated with reductions
in cortical thickness metrics but not cerebellar grey matter
volume. There was a signiﬁcant association between longer
time to reach the saccade target and lower cortical thick-
ness in the parietal lobe and the occipital lobe, but no other
regions of interest. Major saccade amplitude and velocity
gain during smooth pursuit did not correlate signiﬁcantly
Figure 5 Mean cortical thickness and cerebellar grey matter volume for each patient group in each region of interest. Error
bars indicate 95% confidence intervals. Asterisks indicate significant difference between patient groups. AD = Alzheimer’s disease; GM = grey
matter.
Table 3 P-values in the analysis of group differences in cortical thickness in each region of interest (upper section),
and for correlations of oculomotor metrics with cortical thickness (combining both patient groups, but controls
excluded; lower section)
Table of P-values Parietal
thickness
Frontal
thickness
Temporal
thickness
Occipital
thickness
Central
thickness
Cerebellar GM
volume
Group differences
Con versus PCA _0.001 0.005 _0.001 _0.001 _0.001 0.013
Con versus tAD _0.001 0.041 _0.001 0.072 0.005 0.205
PCA versus tAD 0.043 0.790 0.837 0.022 0.341 0.634
Correlations in combined patient group
SWJs in fixation 0.624 0.152 0.980 0.667 0.500 0.003
Int. sac. in fixa 0.005 0.002 0.036 _0.001 0.111 0.801
Saccade time to target 0.027 0.939 0.357 0.037 0.170 0.623
Saccade amplitude error 0.336 0.703 0.600 0.057 0.478 0.993
Velocity gain (pursuit) 0.409 0.849 0.995 0.115 0.881 0.194
Bold highlight indicates significant effects.
aFrequency of intrusive saccades during fixation.
Con = control; GM = grey matter; tAD = typical Alzheimer’s disease; SWJ = square wave jerk.
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with cortical thickness in any of the cortical regions, or
with cerebellar grey matter volume.
Discussion
We describe the ﬁrst detailed assessment of oculomotor func-
tion in patients with PCA as compared with patients with
typical Alzheimer’s disease and healthy controls. In patients
with PCA, the most prominent deﬁcits (where they were
signiﬁcantly worse than not only controls but also patients
with typical Alzheimer’s disease) were in increased time to
saccadic target ﬁxation, increased ﬁrst major saccade latency
and decreased saccade amplitude. The patients with PCA
showed additional deﬁcits (relative to controls) on ﬁxation
stability (more frequent large intrusive saccades and lower
longest period of ﬁxation) and sinusoidal pursuit (lower pur-
suit gain and more saccades per trial). However, the peak
velocity of saccades was normal (after accounting for sac-
cade amplitude) indicating relative preservation of motor as-
pects of eye movement generation.
By contrast, the pattern of oculomotor dysfunction in the
typical Alzheimer’s disease group was characterized (rela-
tive to both patients with PCA and controls) by more
square wave jerks during ﬁxation and increased saccadic
velocity, and showed additional deﬁcits (relative to con-
trols) of lower longest period of ﬁxation, lower pursuit
gain and more saccades per pursuit trial. However, unlike
patients with PCA, patients with typical Alzheimer’s disease
did not differ from controls on any of the saccade task
measures (i.e. normal time to target, major saccade latency
and amplitude, and number of saccades) except their
increased saccade velocity.
Thus patients with PCA showed deﬁcits across all three
ﬁxation, saccade and pursuit tasks with deﬁcits particularly
evident on the saccade task (especially in the overlap con-
dition), whereas typical Alzheimer’s disease patients’ oculo-
motor deﬁcits were largely conﬁned to ﬁxation and pursuit
deﬁcits. The overall greater oculomotor impairment of the
PCA relative to typical Alzheimer’s disease group occurred
despite the fact that the patients with PCA were younger
than the patients with typical Alzheimer’s disease (note that
age was included as a covariate in statistical analyses) and
the patient groups were matched for Mini-Mental State
Examination and disease duration. Here we consider the
theoretical, clinical and anatomical implications of PCA
and typical Alzheimer’s disease performance with regard
to each of the three eye movement behaviours (ﬁxation,
saccade and pursuit) in turn.
Fixation stability
The ﬁndings of impaired ﬁxation stability in PCA and typ-
ical Alzheimer’s disease warrant further discussion. Both
groups exhibited a decreased period of ﬁxation, which
was associated in PCA with increased frequency of large
intrusive saccades and in typical Alzheimer’s disease with
an increased frequency of square wave jerks. These ﬁndings
of impaired ﬁxation stability are consistent with previous
reports of saccadic intrusions during ﬁxation in Alzheimer’s
disease (Jones et al., 1983; Schewe et al., 1999), though it
should be noted that square wave jerks are not speciﬁc to
Alzheimer’s disease, with increased frequency associated
with advancing age (Herishanu and Sharpe, 1981) and
other neurological conditions such as progressive supra-
nuclear palsy, cerebellar disease and Parkinson’s disease
(Troost and Daroff, 1977; White et al., 1983; Rascol
et al., 1991; Rabiah et al., 1997). The increased frequency
of square wave jerks in patients with typical Alzheimer’s
disease likely reﬂects changes in basic oculomotor mechan-
isms rather than higher order cognitive processes, as these
eye movements are not under cognitive control. Our ima-
ging analyses are consistent with this interpretation given
the observed association between square wave jerk fre-
quency and cerebellar grey matter volume but none of
the indices of cortical thickness.
Of particular interest in the PCA data was not only the
identiﬁcation of large saccadic intrusions but also the fact
that these large intrusions occurred with greater frequency
than smaller square wave jerks. This suggests that these
large saccadic intrusions may have a different origin, per-
haps associated with the visual disorientation or visual in-
attention that commonly accompany this syndrome. Again,
the imaging data are consistent with this interpretation;
large saccadic intrusion frequency in the patients with
PCA was signiﬁcantly associated with reductions in cortical
thickness metrics but not (as in the case of square wave
jerks) with cerebellar grey matter volume.
Turning to the clinical impact of these ﬁxation abnorm-
alities, square wave jerks of the kind measured here in typ-
ical Alzheimer’s disease and PCA are not generally
considered to have strongly adverse effects on visual per-
ception. By contrast, these larger saccadic intrusions that
shift gaze to a new location and do not involve a rapid
return to the target mean that the individual may com-
pletely lose track of the target they are trying to monitor.
Indeed, it has previously been proposed in a single case
study, that aberrant involuntary saccadic eye movements
may underlie some PCA patients’ experience of apparent
motion amongst static objects (e.g. letters in a words, or
dots on a page, appear to be moving; Crutch et al., 2011).
What remains unclear is whether the major saccade away
from the target is an involuntary movement, or whether
it reﬂects the beginning of an erroneous voluntary search
process triggered by a minor involuntary movement that,
whilst small, is sufﬁcient to give patients with PCA
the impression that they have lost the target. We therefore
suggest these large intrusions may have two components,
both of which are impaired in PCA: an initial intrusion
(small or large, attributable to basic oculomotor dysfunc-
tion), and an impaired reﬁxation process (attributable to
basic and higher-order perceptual and/or attentional
impairments).
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Saccades: a deficit of target
generation or movement generation?
Previous studies of PCA note the occurrence of oculomotor
apraxia (also known as ocular apraxia; a reduced ability to
make voluntary saccades) on informal clinical testing in an
average of 28% of patients with PCA (consistent with the
33% on clinical assessment in the present study), but the
proportion varies considerably between studies [10%
(Tang-Wai et al., 2004), 27% (Mendez et al., 2002),
38% (Kas et al., 2011), 47% (McMonagle et al., 2006)].
By contrast, our detailed quantitative examination of eye
movements found evidence of oculomotor impairment in
80% of patients with PCA (relative to 17% typical
Alzheimer’s disease and 5% controls), a level between 2
and 8 times greater than those previous clinical estimates.
The receiver operator characteristic analysis also revealed a
high degree of separation between PCA and typical
Alzheimer’s disease groups for saccade amplitude error
(sensitivity 93.8%, speciﬁcity 83.3%). Therefore these
data demonstrate that oculomotor deﬁcits are present in
the vast majority of individuals with PCA and should be
regarded as a core feature of the PCA syndrome. Whilst we
do not propose that this technique should be used in iso-
lation as a diagnostic test, the results suggest sensitive tests
of oculomotor function are also informative at the individ-
ual level. More broadly, these data add to the growing
evidence that investigating eye movements may be helpful
in identifying and differentiating a number of neurodegen-
erative conditions (Garbutt et al., 2008; Boxer et al., 2012).
Furthermore we found a signiﬁcantly greater effect of the
gap/overlap manipulation upon time to ﬁrst ﬁxation upon
the target in the PCA group compared to the typical
Alzheimer’s disease and healthy control groups. The
normal gap/overlap effect has been attributed to a general-
ized warning signal effect arising from the offset of the old
target (Csibra et al., 1997; Abel and Yee, 2002), parietal-
driven disengagement of visual attention from the attended
stimulus (Posner et al., 1984; Fischer and Breitmeyer, 1987;
Fischer and Weber, 1993; Csibra et al., 1997) and a ter-
mination of activity by an active ﬁxation mechanism in the
superior colliculus (Reuter-Lorenz et al., 1991; Kingstone
and Klein, 1993; Tam and Stelmach, 1993; Klein et al.,
1995). The signiﬁcantly exacerbated gap/overlap effect
observed in patients with PCA may reﬂect poor attentional
disengagement from the current focus of ﬁxation. However,
given the superior colliculus’ role in generating eye move-
ments towards new target locations based on a 2D map of
retinotopic space, in patients with PCA weak occipital and
parietal input regarding target location may also lead to a
slow and/or inaccurate build up of ‘hill’ activity within
these superior collicular coordinates. This notion of weak
input to the subcortical oculomotor system from degraded
higher-order cortical spatial representations ﬁts with the
neuroimaging data that showed signiﬁcant associations be-
tween time to reach the target and parietal and occipital
cortical thickness measures. This notion is also consistent
with signiﬁcant correlations between the extent of disrup-
tion of PCA saccade metrics and the extent of their basic,
visuospatial and visuoperceptual impairment in the back-
ground neuropsychological assessment of occipital and par-
ietally-mediated cognitive functions. The ﬁnding of normal
saccadic velocities in patients with PCA adds weight to the
argument that PCA patients’ longer latencies to reach the
target location reﬂect impairment of oculomotor target
identiﬁcation rather than the execution of oculomotor
movements. Regarding the relevance of these ﬁndings to
studies of visual salience and real world perception, it
should be noted that to date PCA scene perception has
only been evaluated using static scene photographs
(Mannan et al., 2009; Foulsham et al., 2011; Shakespeare
et al., 2013). However, the current results regarding oculo-
motor responses to changes in an (albeit very simple) scene
emphasize the critical role not only of spatial attention and
object identiﬁcation but also precise localization of features/
changes in understanding how these individuals perceive
the real world.
Brieﬂy in reference to patients with typical Alzheimer’s dis-
ease, it should also be noted that in contrast to previous stu-
dies of pro-saccades in this population (Fletcher and Sharpe,
1986; Bylsma et al., 1995; Yang et al., 2011, 2013), we did
not see any systematic differences between our typical
Alzheimer’s disease group and the healthy control group,
with the exception of increased peak saccadic velocity (after
controlling for saccade amplitude). Furthermore, two previ-
ous studies have reported a normal gap/overlap effect (Abel
and Yee, 2002; Crawford et al., 2013) whilst one study re-
ported an exaggerated effect (Yang et al., 2013). The results
from the present study add weight to the former position, as
there was no difference in the magnitude of the gap/overlap
effect exhibited by patients with typical Alzheimer’s disease
and controls.
Pursuit function
In the smooth pursuit measures, the PCA and typical
Alzheimer’s disease groups did not differ from one another,
with both groups showing lower gain than the healthy con-
trols and an increased frequency of intrusive saccades (al-
though there was a weak trend to lower pursuit gain in
PCA than typical Alzheimer’s disease). This is consistent
with previous studies of smooth pursuit in typical
Alzheimer’s disease (Fletcher and Sharpe, 1988; Zaccara
et al., 1992; Garbutt et al., 2008). The trace showing im-
paired smooth pursuit in PCA in Fig. 4 was chosen as an
interesting example (this performance is not representative
of the patients with PCA, the majority showed similar per-
formance to patients with typical Alzheimer’s disease in this
task); this pattern is indicative of basic oculomotor dys-
function; this PCA patient is clearly tracking the target
(suggesting that the representation of target motion and
planned gaze location is at least partially preserved), but
does so with multiple saccades and very little smooth
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pursuit (suggesting an impairment in the oculomotor mech-
anism underlying smooth pursuit).
Limitations and future directions
Finally, it is worth considering the potential weaknesses of
this study. Whilst all the patients with PCA met clinical
criteria for the syndrome, and did not exhibit symptoms
suggestive of pathologies other than Alzheimer’s pathology
(e.g. early hallucinations, delusions and ﬂuctuations sug-
gesting Lewy body disease), it remains possible that some
of the participants do not have Alzheimer’s disease, or have
coexistent pathologies (Renner et al., 2004). The PCA and
typical Alzheimer’s disease groups were not matched for
age, with the patients with PCA being younger, as is
typically the case in this syndrome which typically has
age-at-onset in the sixth or seventh decade. However, we
covaried for age in our statistical analyses, and given that
the patients with PCA (who were younger) performed
worse than patients with typical Alzheimer’s disease on
many of the tasks, this suggests that if there is an effect
of age it would result in an underestimate of the differences
between the patients with PCA and typical Alzheimer’s dis-
ease. Furthermore not all participants had concurrent ima-
ging data available; repeating the analyses conducted with
larger sample sizes would increase sensitivity to detect as-
sociations between oculomotor behaviour and speciﬁc cor-
tical subregions such as the parietal and frontal eye ﬁelds.
The experimental design of the saccade task meant that the
ﬁnal trial of each block was theoretically predictable (given
each location was tested in each block) and improved
design would avoid this issue.
One further point (which we do not regard as a limita-
tion) relates to the analysis method for saccadic latency,
amplitude and velocity. Participants’ performance did not
allow straightforward identiﬁcation of the ﬁrst or main sac-
cade towards the target (e.g. making a number of small
saccades near the ﬁxation point before making a saccade
towards the target, or making a number of smaller saccades
towards the target). We therefore developed an algorithm
to deﬁne the main saccade that is clear and reproducible.
However, the combination of patient performance and
choice of analysis method may mean that results of this
algorithm are not interpretable in exactly the same way
as a standard saccadometry experiment, but we do feel
they accurately represent performance in this patient group.
We speculate that the increased frequency of large sac-
cades during ﬁxation in patients with PCA could be due to
spontaneous motor activity; however, an alternative ex-
planation would be greater distractibility or poorer inhibi-
tory control in the patients with PCA. Although we cannot
distinguish between these alternatives objectively on the
basis of the data collected, the subjective experience while
testing the PCA participants was of effortful performance
rather than distractibility; however, it would be interesting
to further investigate this aspect experimentally. One
avenue of future research of interest is to investigate
performance in an antisaccade task. This task requires par-
ticipants to move their eyes in the opposite direction to a
visually presented stimulus (Antoniades et al., 2013) and is
usually considered a marker of inhibitory control (Kaufman
et al., 2010; Crawford et al., 2013). It is possible that this
may help to discriminate between spontaneous motor ac-
tivity versus distractibility or poor inhibitory control.
However in patients with PCA, interpretation in this test
may be clouded by their concomitant left-right disorienta-
tion, simultanagnosia and impairments in saccadic perform-
ance. Nonetheless examination of antisaccade performance
and other oculomotor behaviours such as predictive sac-
cades could expand the current investigation of low-level
control mechanisms to higher-order aspects of oculomotor
control.
Future studies might also capitalize on other imaging
modalities (e.g. diffusion tensor imaging) to look at the
integrity of subcortical structures and white matter tracts
to test the stated hypotheses regarding the role of parietal-
superior colliculus connections in determining oculomotor
behaviour in PCA and their broader impact upon higher-
order perception. Such data would build on the insights
offered by the current study regarding the combined role
of oculomotor dysfunction and higher-order perceptual im-
pairment in explaining the experiences of people with PCA
and the broader population of individuals with dementia-
related visual dysfunction.
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